A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis

Acharyya, Swarnali, Oskarsson, Thordur, Vanharanta, Sakari, Malladi, Srinivas, Kim, Juliet, Morris, Patrick G., Manova-Todorova, Katia, Leversha, Margaret, Hogg, Nancy, Seshan, Venkatraman E., Norton, Larry, Brogi, Edi, Massagué, Joan·2012·Cell
DOI 10.1016/j.cell.2012.04.042

Cited by (1,000)

Items 201–300 of 1,000

  1. OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models
    Myriam Fabre, Cristina Ferrer, Saioa Domínguez-Hormaetxe, Bruno Bockorny, Laura Murias, Oliver Seifert, Stephan A. Eisler, Roland E. Kontermann, Klaus Pfizenmaier, So Young Lee et al. · 2020 · Clinical Cancer Research
  2. Stress signaling in breast cancer cells induces matrix components that promote chemoresistant metastasis
    Jacob Insua‐Rodríguez, Maren Pein, Tsunaki Hongu, Jasmin Meier, Arnaud Descot, Camille Lowy, Etienne D. Braekeleer, Hans‐Peter Sinn, Saskia Spaich, Marc Sütterlin et al. · 2018 · EMBO Molecular Medicine
  3. Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR−/HER2+breast cancers
    Ruth Rodriguez Barrueco, Jiyang Yu, Laura Paula Saucedo-Cuevas, Mireia Oliván, David Llobet‐Navàs, Preeti Putcha, Verónica Castro, Eva Murga-Penas, Ana Collazo-Lorduy, Mireia Castillo-Martín et al. · 2015 · Genes & Development
  4. Research trends in pharmacological modulation of tumor‐associated macrophages
    Neng Wang, Shengqi Wang, Xuan Wang, Yifeng Zheng, Bowen Yang, Juping Zhang, Bo Pan, Jian‐Li Gao, Zhiyu Wang · 2021 · Clinical and Translational Medicine
  5. αvβ3 Integrin and tumour blood vessels — learning from the past to shape the future
    Fevzi Demircioglu, Kairbaan Hodivala‐Dilke · 2016 · Current Opinion in Cell Biology
  6. The emerging roles of macrophages in cancer metastasis and response to chemotherapy
    Luis Rivera Sanchez, Lucia Borriello, David R. Entenberg, John S. Condeelis, Maja H. Oktay, George S. Karagiannis · 2019 · Journal of Leukocyte Biology
  7. Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
    Fusheng Zhang, Haiyang Liu, Meiqi Duan, Guang Wang, Zhenghou Zhang, Yutian Wang, Yiping Qian, Zhi Yang, Xiaofeng Jiang · 2022 · Journal of Hematology & Oncology
  8. ZEB 1‐regulated inflammatory phenotype in breast cancer cells
    Akihiro Katsura, Yusuke Tamura, Satoshi Hokari, Mayumi Harada, Masato Morikawa, Tsubasa Sakurai, Kei Takahashi, Anna Mizutani, Jun Nishida, Yuichiro Yokoyama et al. · 2017 · Molecular Oncology
  9. Galectin-3 Mediates Tumor Cell–Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling
    Wei Zhao, Jaffer A. Ajani, Sushovan Guha, Nobuo Ochi, Rosa F. Hwang, Margarete Hafley, Randy L. Johnson, Robert S. Bresalier, Craig D. Logsdon, Zhiqian Zhang et al. · 2017 · Gastroenterology
  10. Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade
    Xuefeng Wu, Weizhou Zhang, Joan Font-Burgada, Trenis D. Palmer, Alexander S. Hamil, Subhra Kumar Biswas, Michael Poidinger, Nicholas C. Borcherding, Qing Mei Xie, Lesley G. Ellies et al. · 2014 · Proceedings of the National Academy of Sciences
  11. Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis
    Zhe Wang, Shanshan Xiong, Yubin Mao, Mimi Chen, Xiaohong Ma, Xueliang Zhou, Zhenling Ma, Fan Liu, Zhengjie Huang, Qi Luo et al. · 2016 · The Journal of Pathology
  12. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma
    Wei-Ren Liu, Meng‐Xin Tian, Liu‐Xiao Yang, Yuli Lin, Lei Jin, Zhen‐Bin Ding, Ying‐Hao Shen, Yuan‐Fei Peng, Dongmei Gao, Jian Zhou et al. · 2014 · Oncotarget
  13. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53
    S Ramadoss, Gao Guo, C-Y Wang · 2016 · Oncogene
  14. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes
    Xiaodi Li, Wei Chen, Yuhao Jin, Renxing Xue, Jiancheng Su, Zekun Mu, Jiamin Li, Songshan Jiang · 2019 · Biochemical Pharmacology
  15. Lung tumor NF-κB signaling promotes T cell–mediated immune surveillance
    Emily L. Hopewell, Weipeng Zhao, William J. Fulp, Crystina C. Bronk, Alexis S. Lopez, Michael T. Massengill, Scott Joseph Antonia, Esteban Celis, Eric B. Haura, Steven A. Enkemann et al. · 2013 · Journal of Clinical Investigation
  16. MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway
    S. C. Tripathi, Johannes Francois Fahrmann, Müge Çeliktaş, Mitzi Aguilar, Kieren D. Marini, Mohit Kumar Jolly, Hiroyuki Katayama, Hong Wang, Eunice N. Murage, Jennifer B. Dennison et al. · 2017 · Cancer Research
  17. The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity
    Vincenzo Salemme, Giorgia Centonze, Lidia Avalle, Dora Natalini, Alessio Piccolantonio, Pietro Arina, Alessandro Morellato, Ugo Ala, Daniela Taverna, Emilia Turco et al. · 2023 · Frontiers in Oncology
  18. CXCR2+ MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion
    Ha Zhu, Yan Gu, Yiquan Xue, Ming Yuan, Xuetao Cao, Qiuyan Liu · 2017 · Oncotarget
  19. Lung-Seeking Metastases
    Giulia Maria Stella, Stefan Kolling, Silvia Benvenuti, Chandra Bortolotto · 2019 · Cancers
  20. Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells
    Ping‐Pui Wong, José M. Muñoz‐Félix, Maruan Hijazi, Hyo-Jin Kim, Stephen David Robinson, Beatriz de Luxán‐Delgado, Irene Rodríguez‐Hernández, Óscar Maiques, Ya-Ming Meng, Qiong Meng et al. · 2020 · Cell
  21. CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma
    Li Li, Li Xu, Jing Yan, Zuo-Jun Zhen, Yong Ji, Chao-Qun Liu, Wan Yee Lau, Limin Zheng, Jing Xu · 2015 · Journal of Experimental & Clinical Cancer Research
  22. Breast Cancer Metastasis
    Mi Young Kim · 2021 · Advances in experimental medicine and biology
  23. Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells
    Zunyue Zhang, Guohong Lin, Yujing Yan, Xiang Li, Yibing Hu, Jing Wang, Bingjiao Yin, Yaqun Wu, Zhuoya Li, Xiang‐Ping Yang · 2018 · Oncogene
  24. Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression
    Shannon P. Fortin Ensign, Ian T. Mathews, Marc H. Symons, Michael E. Berens, Nhan L. Tran · 2013 · Frontiers in Oncology
  25. Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils
    Ming Yuan, Ha Zhu, Junfang Xu, Yuanyuan Zheng, Xuetao Cao, Qiuyan Liu · 2016 · Journal of Immunology Research
  26. CXCR2 chemokine receptor – a master regulator in cancer and physiology
    Gwendal Lazennec, Krishna Rajarathnam, Ann J. Richmond · 2023 · Trends in Molecular Medicine
  27. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer
    Zhe-Wei Wei, Guangkai Xia, Ying Wu, Wei Chen, Zhen Xiang, Roderich Egbert Schwarz, Rolf A. Brekken, Niranjan Awasthi, Yu-Long He, Chang-Hua Zhang · 2015 · Cancer Letters
  28. The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution
    Guizhen Wang, Xin Cheng, Bo Zhou, Zhesheng Wen, Yunchao Huang, Hao-Bin Chen, Gaofeng Li, Zhi-Liang Huang, Yongchun Zhou, Lin Feng et al. · 2015 · eLife
  29. A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis
    Zhenxian Xiang, Z-J Zhou, G-K Xia, X-H Zhang, Z-W Wei, J-T Zhu, Jie Yu, WenYing CHEN, Yun He, Roderich Egbert Schwarz et al. · 2017 · Oncogene
  30. Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1
    Ya‐Ling Hsu, Yi‐Jen Chen, Wei‐An Chang, Shu‐Fang Jian, Hsiao-Li Fan, Jaw‐Yuan Wang, Po‐Lin Kuo · 2018 · International Journal of Molecular Sciences
  31. S100 proteins as therapeutic targets
    Anne R. Bresnick · 2018 · Biophysical Reviews
  32. Biological Adaptations of Tumor Cells to Radiation Therapy
    Ángeles Carlos‐Reyes, Marcos Agustín Muñiz-Lino, Susana Romero‐Garcia, César López‐Camarillo, Olga N. Hernández-de la Cruz · 2021 · Frontiers in Oncology
  33. Cytokine Regulation of Metastasis and Tumorigenicity
    Min Yao, Gage Brummer, Diana S. Acevedo, Nikki Cheng · 2016 · Advances in cancer research
  34. Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies
    Hanxin Liu, Huifang Zhao, Yu Sun · 2021 · Seminars in Cancer Biology
  35. An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition
    Helen L. Young, Emily J. Rowling, Mattia Bugatti, Emanuele Giurisato, Nadia Luheshi, Imanol Arozarena, Juan Carlos Acosta, Jivko A. Kamarashev, Dennie Tompers Frederick, Zachary Aaron Cooper et al. · 2017 · The Journal of Experimental Medicine
  36. Triple-Negative Breast Cancer Cells Recruit Neutrophils by Secreting TGF-β and CXCR2 Ligands
    Shuvasree SenGupta, Lauren E. Hein, Yang Xu, Jason Zhang, Jamie R. Konwerski, Ye Li, Craig N. Johnson, Dawen Cai, Janet Lynn Smith, Carole A. Parent · 2021 · Frontiers in Immunology
  37. MyD88 and its divergent toll in carcinogenesis
    Rosalba Salcedo, Christophe Cataisson, Uzma Ayesha Hasan, Stuart H. Yuspa, Giorgio Trinchieri · 2013 · Trends in Immunology
  38. HOXB13 Mediates Tamoxifen Resistance and Invasiveness in Human Breast Cancer by Suppressing ERα and Inducing IL-6 Expression
    Nilay Shah, Kideok Jin, Leigh-Ann Cruz, Sunju Park, Helen Sadik, Soonweng Cho, Chirayu Pankaj Goswami, Harikrishna Nakshatri, Rajnish A. Gupta, Howard Y. Chang et al. · 2013 · Cancer Research
  39. CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin β1/FAK/AKT signaling
    Zhixiong Wang, Zhao Wang, Guanghua Li, Hui Wu, Kaiyu Sun, Jianhui Chen, Yun Feng, Chuangqi Chen, Shirong Cai, Jianbo Xu et al. · 2016 · Cancer Letters
  40. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins
    An Zou, Diana Lambert, Hung‐Wen Yeh, Ken Yasukawa, Fariba Behbod, Fang Fan, Nikki Cheng · 2014 · BMC Cancer
  41. Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models
    Li Shen, Anette Sundstedt, Michael J. Ciesielski, Kiersten Marie Miles, Mona Celander, Remi M. Adelaiye-Ogala, Ashley R. Orillion, Eric Stefano Ciamporcero, Swathi Ramakrishnan, Leigh Ellis et al. · 2014 · Cancer Immunology Research
  42. CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition
    Yongning Lu, Baijun Dong, Fan Xu, Yunze Xu, Jiahua Pan, Jiajia Song, Jin Zhang, Yong Huang, Wei Xue · 2019 · Cell Communication and Signaling
  43. Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting
    Antonella Sistigu, Francesca Di Modugno, Gwenola Manic, Paola Nisticò · 2017 · Cytokine & Growth Factor Reviews
  44. CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer
    Weilong Chen, Yuanyuan Qin, Dong Wang, Lei Zhou, Yin Liu, Sheng Chen, Liang Yin, Yaoxing Xiao, Xiao-Hong Yao, Xiao‐Li Yang et al. · 2018 · PLoS Biology
  45. The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers
    Alex J. Gooding, Bing Zhang, Lalith S. Gunawardane, Abigail Beard, Saba Valadkhan, William P. Schiemann · 2018 · Oncogene
  46. RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression
    Zhenyu Liu, Ming Zheng, Yiming Li, Xinyu Fan, Jianchao Wang, Zhu‐Chun Li, Hai‐Jiao Yang, Jingmin Yu, Jian Cui, Jian‐Li Jiang et al. · 2019 · Theranostics
  47. Distinct prognostic values of S100 mRNA expression in breast cancer
    Shizhen Zhang, Zhen Wang, Weiwei Liu, Rui Lei, Jinlan Shan, Ling Li, Xiaochen Wang · 2017 · Scientific Reports
  48. A Novel Selective Inhibitor JBI-589 Targets PAD4-Mediated Neutrophil Migration to Suppress Tumor Progression
    Hui Deng, Cindy Lin, Laura Garcia-Gerique, Shuyu Fu, Zachary Cruz, Erin E. Bonner, Matthew J. Rosenwasser, Sridharan Rajagopal, M Naveen Sadhu, Chandru Gajendran et al. · 2022 · Cancer Research
  49. Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice
    José A. Guerrero, Cavan Bennett, Louise van der Weyden, Harriet McKinney, Melody Chin, Paquita Nurden, Zoe McIntyre, Emma L. Cambridge, Jeanne Estabel, Hannah Wardle‐Jones et al. · 2014 · Blood
  50. Myeloid‐Derived Suppressor Cells and Therapeutic Strategies in Cancer
    Hiroshi Katoh, Masahiko Watanabe · 2015 · Mediators of Inflammation
  51. Roadblocks to translational advances on metastasis research
    Thomas Brabletz, David C. Lyden, Patricia Schriver Steeg, Zena Werb · 2013 · Nature Medicine
  52. Identification of EDIL3 on extracellular vesicles involved in breast cancer cell invasion
    Jeong‐Eun Lee, Pyong‐Gon Moon, Young‐Eun Cho, Young‐Bum Kim, In‐San Kim, Ho-Yong Park, Moon‐Chang Baek · 2015 · Journal of Proteomics
  53. Circ_0026344 restrains metastasis of human colorectal cancer cells via miR-183
    Tao Shen, Xianshuo Cheng, Xin Liu, Cuifeng Xia, Hongtao Zhang, Dingguo Pan, Xuan Zhang, Yunfeng Li · 2019 · Artificial Cells Nanomedicine and Biotechnology
  54. Roles of Neutrophils in Glioma and Brain Metastases
    Ya-Jui Lin, Kuo‐Chen Wei, Pin‐Yuan Chen, Michael K. Lim, Tsong‐Long Hwang · 2021 · Frontiers in Immunology
  55. Fas and TRAIL ‘death receptors’ as initiators of inflammation: Implications for cancer
    Sean P. Cullen, Séamus J. Martin · 2015 · Seminars in Cell and Developmental Biology
  56. Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
    Zhang, Peitao, Guan, Haixia, Yuan, Shukai, Cheng, Huili, Zheng, Jian, Zhang, Zhenlei, Liu, Yifan, Yu, Yang, Meng, Zhaowei, Zheng, Xiangqian et al. · 2022 · Nature Communications
  57. Obesity and prostate cancer — microenvironmental roles of adipose tissue
    Achinto Saha, Mikhail G. Kolonin, John DiGiovanni · 2023 · Nature Reviews Urology
  58. The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications
    Siyao Liu, Wenchuan Wu, Yueshan Du, Hanlin Yin, Qiangda Chen, Weisheng Yu, Wenquan Wang, Jun Yu, Liang Liu, Wenhui Lou et al. · 2023 · Molecular Cancer
  59. TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth
    Svasti Haricharan, Powel H. Brown · 2015 · Proceedings of the National Academy of Sciences
  60. Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism
    Cátia Monteiro, Lauritz Miarka, María Perea-García, Neibla Priego, Pedro García‐Gómez, Laura Álvaro‐Espinosa, Ana de Pablos-Aragoneses, Natalia Yebra, Diana Retana, Patricia Baena et al. · 2022 · Nature Medicine
  61. The Role of CXC Chemokines in Cancer Progression
    Tiantian Wu, Wannian Yang, Aiqin Sun, Zhixiao Wei, Qiong Lin · 2022 · Cancers
  62. The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets
    Margarita Isabel Palacios Arreola, Karen Elizabeth Nava Castro, Julieta I. Castro, Eduardo Alberto García-Zepeda, Julio César Carrero, Jorge Morales‐Montor · 2014 · Journal of Immunology Research
  63. Mechanics and Actomyosin-Dependent Survival/Chemoresistance of Suspended Tumor Cells in Shear Flow
    Ying Xin, Xi Chen, Xin Tang, Keming Li, Mo Yang, William Tai, Yiyao Liu, Youhua Tan · 2019 · Biophysical Journal
  64. Translational Horizons in the Tumor Microenvironment: Harnessing Breakthroughs and Targeting Cures
    Yu Sun · 2015 · Medicinal Research Reviews
  65. Mechanisms of action of tasquinimod on the tumour microenvironment
    Éric Raymond, Angus George Dalgleish, J.‐E. Damber, Matthew Raymond Smith, Роберто Пили · 2013 · Cancer Chemotherapy and Pharmacology
  66. Access to Follicular Dendritic Cells Is a Pivotal Step in Murine Chronic Lymphocytic Leukemia B-cell Activation and Proliferation
    Kristina Heinig, Marcel Gätjen, Michael Grau, Vanessa Stache, Ioannis Anagnostopoulos, Kerstin Gerlach, Raluca Aura Niesner, Zoltán Cseresnyés, Anja Erika Hauser, Peter Lenz et al. · 2014 · Cancer Discovery
  67. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment
    Atsuko Deguchi, Takeshi Tomita, Umeharu Ohto, Kazuhiro Takemura, Akio Kitao, Sachiko Akashi‐Takamura, Kensuke Miyake, Yoshiro Maru · 2015 · Oncogene
  68. CXCL1 promotes arteriogenesis through enhanced monocyte recruitment into the peri-collateral space
    Mark H. M. Vries, Allard Wagenaar, Sanne E. L. Verbruggen, Daniël G. M. Molin, Mark J. Post · 2014 · Angiogenesis
  69. Neutrophils, a candidate biomarker and target for radiation therapy?
    Antoine Schernberg, Pierre Blanchard, Cyrus Chargari, Éric Deutsch · 2017 · Acta Oncologica
  70. CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ
    Hangyi H. Yan, Jian Dong Jiang, Yanli Pang, B.R. Achyut, Michael M. Lizardo, Xin‐hua Liang, Kent W. Hunter, Chand Khanna, Christine M. Hollander, Yang Li · 2015 · Cancer Research
  71. Circulating galectins -2, -4 and -8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis
    C Chen, Carrie A. Duckworth, Bo Fu, David Mark Pritchard, Jonathan Michael Rhodes, Lu‐Gang Yu · 2014 · British Journal of Cancer
  72. Myeloid Derived Hypoxia Inducible Factor 1-alpha Is Required for Protection against Pulmonary Aspergillus fumigatus Infection
    Shepardson, Kelly M., Jhingran, Anupam, Caffrey, Alayna, Obar, Joshua J., Suratt, Benjamin T., Berwin, Brent L., Hohl, Tobias M., Cramer, Robert A. · 2014 · PLoS Pathogens
  73. The fibrotic and immune microenvironments as targetable drivers of metastasis
    Luke Boulter, Esme Bullock, Zeanap Mabruk, Valerie G. Brunton · 2020 · British Journal of Cancer
  74. Histamine in cancer immunology and immunotherapy. Current status and new perspectives
    María de la Paz Sarasola, Mónica A. Táquez Delgado, Melisa B. Nicoud, Vanina A. Medina · 2021 · Pharmacology Research & Perspectives
  75. IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
    Yinan Liu, Tzu‐Hua Chang, Meng‐Feng Tsai, Shang‐Gin Wu, Tzu-Hsiu Tsai, Hsuan‐Yu Chen, Sung‐Liang Yu, James Chih‐Hsin Yang, Jin‐Yuan Shih · 2015 · Oncotarget
  76. Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors
    Adriana Bajetto, Alessandra Pattarozzi, Alessandro Corsaro, Federica Barbieri, Antonio Daga, Alessia G. Bosio, Monica Gatti, Valerio Pisaturo, Rodolfo Sirito, Tullio Florio · 2017 · Frontiers in Cellular Neuroscience
  77. Inhibition of CXCL1-CXCR2 axis ameliorates cisplatin-induced acute kidney injury by mediating inflammatory response
    Peng Liu, Xinxiu Li, Weixing Lv, Zhaojun Xu · 2019 · Biomedicine & Pharmacotherapy
  78. Current challenges in metastasis research and future innovation for clinical translation
    Amelia L. Parker, Madeleine Benguigui, Jaime Fornetti, Erica T. Goddard, Serena Lucotti, Jacob Insua‐Rodríguez, Adrian P. Wiegmans · 2022 · Clinical & Experimental Metastasis
  79. Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling
    Ghada M. Sharif, Marcel O. Schmidt, Chunling Yi, Z Hu, Bassem R. Haddad, Eric F. Glasgow, Anna Tate Riegel, Anton Wellstein · 2015 · Oncogene
  80. ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas
    Hanseul Yang, Daniel Schramek, Rene C. Adam, Brice E. Keyes, Ping Wang, Deyou Zheng, Elaine V. Fuchs · 2015 · eLife
  81. Metformin as a senostatic drug enhances the anticancer efficacy of CDK4/6 inhibitor in head and neck squamous cell carcinoma
    Qinchao Hu, Jianmin Peng, Laibo Jiang, Wuguo Li, Qiao Su, Jiayu Zhang, Huan Li, Ming Song, Bin Cheng, Juan Xia et al. · 2020 · Cell Death and Disease
  82. Exploiting inflammation for therapeutic gain in pancreatic cancer
    Colin William Steele, Nigel Balfour Jamieson, T.R.J. Evans, C. J. McKay, Owen James Sansom, Jennifer P. Morton, C R Carter · 2013 · British Journal of Cancer
  83. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial–mesenchymal transition
    Bin Zhang, Yan Yang, Xiaoting Shi, Wanyu Liao, Min Chen, Alfred S.L. Cheng, Hongli Yan, Cheng Fang, Shu Zhang, Guifang Xu et al. · 2014 · Cancer Letters
  84. A single-cell atlas deconstructs heterogeneity across multiple models in murine traumatic brain injury and identifies novel cell-specific targets
    Ruchira Menka Jha, Dhivyaa Rajasundaram, Chaim T. Sneiderman, Brent Thomas Schlegel, Casey O’Brien, Zujian Xiong, Keri L. Janesko‐Feldman, Ria Trivedi, Vincent Vagni, Benjamin E. Zusman et al. · 2024 · Neuron
  85. TMEM2 Is a SOX4-Regulated Gene That Mediates Metastatic Migration and Invasion in Breast Cancer
    Hyeseung Lee, Hani Goodarzi, Sohail F. Tavazoie, Claudio R. Alarcón · 2016 · Cancer Research
  86. One microenvironment does not fit all: heterogeneity beyond cancer cells
    Ik Sun Kim, Xiang H.-F. Zhang · 2016 · Cancer and Metastasis Reviews
  87. Circulating Tumor Cell-Neutrophil Tango along the Metastatic Process
    Massimo Saini, Barbara Maria Szczerba, Nicola Aceto · 2019 · Cancer Research
  88. Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE2
    Yuan Rong, Chunhui Yuan, Zhen Qu, Hu Zhou, Qing Guan, Na Yang, Xiaohua Leng, Lang Bu, Ke Wu, Xinghuan Wang · 2016 · Scientific Reports
  89. Senescence in polyploid giant cancer cells: A road that leads to chemoresistance
    Bharadwaj, Deblina, Mandal, Mahitosh · 2020 · Cytokine & Growth Factor Reviews
  90. Adipose-derived mesenchymal stem cells and extracellular vesicles confer antitumor activity in preclinical treatment of breast cancer
    Tao Li, Xiaohe Zhou, Jingzhe Wang, Ziyao Liu, Han Sen, Lu Wan, Xiaochun Sun, Huabiao Chen · 2020 · Pharmacological Research
  91. Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance
    Derek W. Edwardson, Justin Boudreau, Jonathan Mapletoft, Carita Lannér, A. Thomas Kovala, Amadeo Mark Parissenti · 2017 · PLoS ONE
  92. Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis
    Hong-Yan Xie, Zhimin Shao, Da‐Qiang Li · 2017 · 癌症：英文版
  93. Targeting S100A9–ALDH1A1–Retinoic Acid Signaling to Suppress Brain Relapse in EGFR -Mutant Lung Cancer
    Anup Kumar Biswas, Seoyoung Han, Yifan Tai, Wanchao Ma, Courtney Coker, S. Aidan Quinn, Ahmad Rushdi Shakri, Timothy James Zhong, Hanna Scholze, Galina G. Lagos et al. · 2022 · Cancer Discovery
  94. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
    Grace O’Malley, Madelon T. Heijltjes, Aileen M. Houston, Sweta Rani, Thomas Ritter, Laurence John Egan, Aideen E. Ryan · 2016 · Oncotarget
  95. CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis
    Chengcheng Yang, Haochen Yu, Rui Chen, Kai Xiong Tao, Jian Lei, Meixi Peng, Xiaotian Li, Manran Liu, Shengchun Liu · 2019 · International Journal of Oncology
  96. Tumor-associated macrophages promote resistance of hepatocellular carcinoma cells against sorafenib by activating CXCR2 signaling
    Hao‐Chen Wang, Lin-Ya Haung, Chih‐Jung Wang, Ying‐Jui Chao, Ya‐Chin Hou, Chia‐Jui Yen, Yan‐Shen Shan · 2022 · Journal of Biomedical Science
  97. The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer
    Tiede, Stefanie, Meyer-Schaller, Nathalie, Kalathur, Ravi Kiran Reddy, Ivanek, Robert, Fagiani, Ernesta, Schmassmann, Philip, Stillhard, Patrick, Häfliger, Simon, Kraut, Norbert, Schweifer, Norbert et al. · 2018 · Oncogenesis
  98. CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma
    Shiruyeh Schokrpur, Junhui Hu, Diana L. Moughon, Peijun Liu, Lucia Christiana Lin, Kip J. Hermann, Serghei Mangul, Wei Guan, Matteo A. Pellegrini, Hua Xu et al. · 2016 · Scientific Reports
  99. Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer
    Haoran Feng, Kun Liu, Xiaonan Shen, Juyong Liang, Changgang Wang, Weihua Qiu, Xi Cheng, Ren Zhao · 2020 · Cell Death and Disease
  100. Promising targets of chrysin and daidzein in colorectal cancer: Amphiregulin, CXCL1, and MMP-9
    Abeer Salama, Rasha Mosa Allam · 2020 · European Journal of Pharmacology